The old has to give way to the new, and that’s certainly the case with the arrival of the Nintendo Switch 2. Succeeding the current iteration later this year, Nintendo is already planning to cease ...
“Microplastics are like rafts — a bacteria on its own might not be able to swim down a river, but riding in its biofilm on a tiny bit of plastic it can be disseminated into many different ...
Senior fellow for Middle East and African Studies at the Council on Foreign Relations, Steven Cook joins Katy Tur to provide the latest on President Trump’s hostage negotiator breaking long ...
The STARI trial (NCT06832306), a Phase 2 feasibility study, will explore the potential of transvenous diaphragm neurostimulation-assisted ventilation (DNAV) in mechanically ventilated patients with ...
Biofilms, ubiquitous bacterial communities embedded ... DOI: 10.1038/s41467-024-55602-2 ...
Israel's government says it supports a US proposal to extend the first phase of the ceasefire in Gaza through Ramadan and Passover, though Hamas has insisted on negotiating the truce's second ...
Talks on the second phase of the ceasefire between Israel and Hamas have made no progress so far and it is unclear whether they would resume on Saturday, a senior Hamas official said.
Register today at no cost to our Explorer Insights subscription and access more of the 4C Offshore database and additional functionality such as tailored notifications, enhanced search capabilities.
Even purely digital changes can take decades, Brooks points to the internet's transition from IPv4, which can only address about 2 billion devices—far fewer than the number of people on Earth ...
Sledgehammer-wielding thieves who smashed their way into Blenheim Palace managed to steal a £2.8m gold toilet in just five minutes, a court has heard. The toilet, an artwork by Italian artist ...
Toyota has unveiled its new third-generation fuel cell system, marking a significant step toward its goal of achieving a hydrogen-based society. The system, known as the 3rd Gen FC System, has ...
The company's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH (metabolic dysfunction-associated steatohepatitis). Pemvidutide has successfully ...